PAPPAS ARTHUR M

CIK 00011895436 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001189543

Recent Transactions

50 trades

Conversion
Liquidia Technologies Inc
Series C Preferred Stock, par value $0.001 per share
2018-07-30−1,481,553→ 0 total
Conversion
Liquidia Technologies Inc
Common Stock, par value $0.001 per share
2018-07-30+191,788→ 191,788 total
Conversion
Liquidia Technologies Inc
Series D Preferred Stock, par value $0.001 per share
2018-07-30−1,637,091→ 0 total
Conversion
Liquidia Technologies Inc
Common Stock, par value $0.001 per share
2018-07-30+97,287→ 289,075 total
Conversion
Kezar Life Sciences, Inc.$KZR
Series B Preferred Stock, par value $0.001 per share
2018-06-25+290,924→ 0 total
Conversion
Kezar Life Sciences, Inc.$KZR
Common Stock, par value $0.001 per share
2018-06-25+23,894→ 23,894 total
Conversion
Kezar Life Sciences, Inc.$KZR
Series B Preferred Stock, par value $0.001 per share
2018-06-25+23,894→ 0 total
Conversion
Kezar Life Sciences, Inc.$KZR
Common Stock, par value $0.001 per share
2018-06-25+290,924→ 290,924 total
Disposition to Issuer
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-03-01$40.26/sh−8,897→ 0 total
Disposition from Tender
CoLucid Pharmaceuticals, Inc.
Common Stock
2017-03-01$46.50/sh−5,528→ 0 total
Disposition from Tender
CoLucid Pharmaceuticals, Inc.
Common Stock
2017-03-01$46.50/sh−116,317→ 0 total
Disposition to Issuer
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-03-01$36.50/sh−5,954→ 0 total
Disposition from Tender
CoLucid Pharmaceuticals, Inc.
Common Stock
2017-03-01$46.50/sh−1,871,049→ 0 total
Award
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2016-05-10+8,897→ 8,897 total
Purchase
CoLucid Pharmaceuticals, Inc.
Common Stock
2015-05-11$10.00/sh+282,440→ 1,871,049 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series A Convertible Preferred Stock
2015-05-11−578,297→ 0 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2015-05-11−675,588→ 0 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2015-05-11−334,722→ 0 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2015-05-11−20,808→ 0 total
Conversion
CoLucid Pharmaceuticals, Inc.
Common Stock
2015-05-11+1,588,607→ 1,588,609 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2015-05-11−41,996→ 0 total
Conversion
CoLucid Pharmaceuticals, Inc.
Series A Convertible Preferred Stock
2015-05-11−35,953→ 0 total
Purchase
CoLucid Pharmaceuticals, Inc.
Common Stock
2015-05-11$10.00/sh+17,560→ 116,317 total
Conversion
CoLucid Pharmaceuticals, Inc.
Common Stock
2015-05-11+98,757→ 98,757 total
Award
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2015-05-05+5,954→ 5,954 total
Exercise/Conversion
CoLucid Pharmaceuticals, Inc.
Common Stock
2015-03-23$4.07/sh+5,528→ 5,528 total
Exercise/Conversion
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2015-03-23−5,528→ 0 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2015-01-12+334,722→ 334,722 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series A Convertible Preferred Stock
2015-01-12+462,637→ 462,637 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series A Convertible Preferred Stock
2015-01-12+28,763→ 28,763 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2015-01-12+540,470→ 540,470 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2015-01-12+33,597→ 33,597 total
Purchase
CoLucid Pharmaceuticals, Inc.
Series C Convertible Preferred Stock
2015-01-12+20,808→ 20,808 total
Sale
CHIMERIX INC
Common Stock
2013-10-23$15.51/sh−216,840→ 830,695 total
Conversion
CHIMERIX INC
Common Stock
2013-04-16+892,591→ 1,047,535 total
Conversion
CHIMERIX INC
Series F Preferred Stock
2012-04-16−3,168,706→ 0 total
Award
ATHEROGENICS INC
Non-qualified stock option (right to buy)
2007-06-29+6,000→ 6,000 total
Purchase
ATHEROGENICS INC
Common stock
2006-04-27$14.03/sh+3,000→ 11,000 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−9,250→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Common Stock
2003-09-25$14.50/sh−3,600→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−5,000→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−12,000→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−2,352→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−7,926→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−3,001→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−3,208→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−6,000→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−8,432→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−4,242→ 0 total
Disposition to Issuer
QUINTILES TRANSNATIONAL CORP
Stock Option (right to buy)
2003-09-25−4,467→ 0 total

Companies

Recent Filings

Address

C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 340

DURHAM, NC, 27713

View on SEC.gov